Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.
暂无分享,去创建一个
J. Németh | J. M. Petrash | D. LaBarbera | B. Laffin | Jessica Ponder | Anna Énzsöly | Kun-Che Chang
[1] P. Suryanarayana,et al. The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis , 2012, PloS one.
[2] K. Ramana,et al. A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases , 2012, Expert opinion on investigational drugs.
[3] Maqsood Ahmad,et al. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients , 2011, International journal of food sciences and nutrition.
[4] F. Tsai,et al. Efficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients. , 2011, Journal of medicinal food.
[5] M. Kahook,et al. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells , 2011, Molecular vision.
[6] G. Liou,et al. Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes , 2011, Diabetes.
[7] Ling-Ling Zhu,et al. The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells , 2010, Cell Stress and Chaperones.
[8] K. Ramana,et al. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. , 2007, Investigative ophthalmology & visual science.
[9] P. Suryanarayana,et al. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. , 2007, Molecular vision.
[10] K. Ramana,et al. Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. , 2007, Free radical biology & medicine.
[11] K. Ramana,et al. Aldose Reductase Mediates the Lipopolysaccharide-induced Release of Inflammatory Mediators in RAW264.7 Murine Macrophages* , 2006, Journal of Biological Chemistry.
[12] K. Ramana,et al. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages. , 2006, Cytokine.
[13] Byung Hak Kim,et al. Down-regulatory effect of quercitrin gallate on nuclear factor-kappa B-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. , 2005, Biochemical pharmacology.
[14] H. Park,et al. Cutting Edge: Direct Interaction of TLR4 with NAD(P)H Oxidase 4 Isozyme Is Essential for Lipopolysaccharide-Induced Production of Reactive Oxygen Species and Activation of NF-κB1 , 2004, The Journal of Immunology.
[15] J. Tuo,et al. Endotoxin-induced uveitis in cyclooxygenase-2-deficient mice. , 2004, Investigative ophthalmology & visual science.
[16] P. Suryanarayana,et al. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. , 2004, Molecular vision.
[17] M. Dal Monte,et al. A new approach against sugar cataract through aldose reductase inhibitors. , 1999, Experimental eye research.
[18] A. Kok,et al. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation , 1999, Diabetologia.
[19] S. Chakrabarti,et al. Increased Renal Aldose Reductase Activity, Immunoreactivity, and mRNA in Streptozocin-Induced Diabetic Rats , 1989, Diabetes.
[20] J. Kinoshita,et al. The pharmacology of aldose reductase inhibitors. , 1985, Annual review of pharmacology and toxicology.
[21] A. Treasurywala,et al. N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. , 1984, Journal of medicinal chemistry.